[1]陈晓燕,罗金键.CXCL8在结直肠癌组织中的表达及其临床意义[J].新乡医学院学报,2018,35(6):505-508.[doi:10.7683/xxyxyxb.2018.06.014]
 CHEN Xiao-yan,LUO Jin-jian.Expression and clinical significance of CXCL8 in colorectal cancer tissue[J].Journal of Xinxiang Medical University,2018,35(6):505-508.[doi:10.7683/xxyxyxb.2018.06.014]
点击复制

CXCL8在结直肠癌组织中的表达及其临床意义
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
35
期数:
2018年6
页码:
505-508
栏目:
临床研究
出版日期:
2018-06-05

文章信息/Info

Title:
Expression and clinical significance of CXCL8 in colorectal cancer tissue
作者:
陈晓燕罗金键
(郑州大学附属郑州中心医院消化内科,河南 郑州 450000)
Author(s):
CHEN Xiao-yanLUO Jin-jian
(Department of Gastroenterology,Zhengzhou Central Hospital Affiliated to Zhengzhou University,Zhengzhou 450000,Henan Province,China)
关键词:
结直肠癌CXCL8临床病理参数
Keywords:
colorectal cancerCXCL8clinicopathological parameters
分类号:
R735
DOI:
10.7683/xxyxyxb.2018.06.014
文献标志码:
A
摘要:
目的 探讨CXCL8 在结直肠癌组织及癌旁组织中的表达,分析其与结直肠癌患者临床病理参数的相关性。方法 选择2014年11月至2016年11月于郑州市中心医院胃肠外科行手术切除的60例结直肠癌患者的癌组织及癌旁组织为研究对象,所有标本经病理学证实。免疫组织化学法和实时荧光定量聚合酶链反应检测CXCL8蛋白和mRNA在结直肠癌组织及癌旁组织中的表达。结果 CXCL8 mRNA在结直肠癌组织和癌旁组织中的表达分别为157.6±26.2和42.7±9.6,CXCL8 mRNA在结直肠癌组织中的表达显著高于癌旁组织(P<0.05)。CXCL8蛋白在结直肠癌组织和癌旁组织中的阳性表达率分别为83.3%(50/60)和25.0%(15/60),CXCL8蛋白在结直肠癌组织中的阳性表达率高于癌旁组织(χ2=41.10,P<0.01);CXCL8在结直肠癌组织中的表达与淋巴结转移、肿瘤分期有关(P<0.05),与结直肠癌患者的年龄、性别及结直肠癌分化程度无相关性(P>0.05)。结论 CXCL8在结直肠癌组织中呈高表达,且与结直肠癌患者的淋巴结转移情况、肿瘤分期有相关性。
Abstract:
Objective To detect the expression of CXCL8 in colorectal tumor tissues and marginal tissues,and analyze the correlation between CXCL8 and clinicopathological parameters.Methods Sixty colorectal cancer specimens and the marginal tissues were collected from the colorectal cancer patients who were surgically removed in gastrointestinal surgery in Zhengzhou Central Hospital Affiliated to Zhengzhou University from November 2014 to November 2016 and were all confirmed by pathology.The expression of CXCL8 protein and mRNA in colorectal tumor tissues and marginal tissues was detected by immunohistochemistry and real time fluorescent quantitation polymerase chain reaction respectively.Results The expression of CXCL8 mRNA in colorectal tumor tissues and marginal tissues was 157.6±26.2 and 42.7±9.6.The expression of CXCL8 mRNA in colorectal tumor tissues was higher than that in the marginal tissues(P<0.05).The positive expression rate of CXCL8 protein in the colorectal tumor tissue and marginal tissue was 83.3%(50/60) and 25.0%(15/60),respectively.The positive expression rate of CXCL8 in the colorectal tumor tissues was higher than that in the marginal tissues(χ2=41.10,P<0.01).The expression of CXCL8 in colorectal tumor tissues was correlated with lymph node metastasis and tumor staging(P<0.01).The expression of CXCL8 in colorectal tumor tissues had not correlation with age,gender and differentiated degree colorectal tumor(P>0.05).Conclusion CXCL8 has high expression in colorectal cancer tissues,and it is closely related to the condition of lymph node metastasis and tumor staging in patients with colorectal cancer.

参考文献/References:

[1] SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2015[J].CA Cancer J Clin,2015,65(1):5-29.
[2] 寇卫政,杨晓煜,褚秀峰,等.消癌平注射液联合CapeOX方案治疗晚期结直肠癌疗效观察[J].新乡医学院学报,2016,33(6):500-503.
[3] HOLZEL D,ECKEL R,ENGEL J.Colorectal cancer metastasis.Frequency,prognosis,and consequences[J].Chirurg,2009,80(4):331-340.
[4] HENDRY S A,FARNSWORTH R H,SOLOMON B,et al.The role of the tumor vasculature in the host immune response:implications for therapeutic strategies targeting the tumor microenvironment[J].Front Immunol,2016,7:621.
[5] LIU Q,LI A,TIAN Y,et al.The CXCL8-CXCR1/2 pathways in cancer[J].Cytokine Growth Factor Rev,2016,31:61-71.
[6] ALFARO C,TEIJEIRA A,ONATE C,et al.Tumor-produced interleukin-8 attracts human myeloid-derived suppressor cells and elicits extrusion of neutrophil extracellular traps(NETs)[J].Clin Cancer Res,2016,22(15):3924-3936.
[7] VISCIANO C,LIOTTI F,PREVETE N,et al.Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway[J].Oncogene,2015,34(40):5175-5186.
[8] LI Y,LIU L,YIN Z,et al.Effect of targeted silencing of IL-8 on in vitro migration and invasion of SKOV3 ovarian cancer cells[J].Oncol Lett,2017,13(2):567-572.
[9] MAHASNEH A,AL-SHAHERI F,JAMAL E.Molecular biomarkers for an early diagnosis,effective treatment and prognosis of colorectal cancer:current updates[J].Exp Mol Pathol,2017,102(3):475-483.
[10] VERMA M,KUMAR V.Epigenetic biomarkers in colorectal cancer[J].Mol Diagn Ther,2017,21(2):153-165.
[11] ALTARA R,MALLAT Z,BOOZ G W,et al.The CXCL10/CXCR3 axis and cardiac inflammation:implications for immunotherapy to treat infectious and noninfectious diseases of the heart[J].J Immunol Res,2016,2016:4396368.
[12] BIALAS M,FISZER D,ROZWADOWSKA N,et al.The role of IL-6,IL-10,TNF-alpha and its receptors TNFR1 and TNFR2 in the local regulatory system of normal and impaired human spermatogenesis[J].Am J Reprod Immunol,2009,62(1):51-59.
[13] KAKINUMA T,HWANG S T.Chemokines,chemokine receptors,and cancer metastasis[J].J Leukoc Biol,2006,79(4):639-651.
[14] LIN Y C,WEI P L,TSAI Y T,et al.Pb(2)(+) induced IL-8 gene expression by extracellular signal-regulated kinases and the transcription factor,activator protein 1,in human gastric carcinoma cells[J].Environ Toxicol,2015,30(3):315-322.
[15] CHEN Y,SHI M,YU G Z,et al.Interleukin-8,a promising predictor for prognosis of pancreatic cancer[J].World J Gastroenterol,2012,18(10):1123-1129.
[16] GHADJAR P,RUBIE C,AEBERSOLD D M,et al.The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer[J].Int J Cancer,2009,125(4):741-745.
[17] BREW R,ERIKSON J S,WEST D C,et al.Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro[J].Cytokine,2000,12(1):78-85.
[18] BAILEY C,NEGUS R,MORRIS A,et al.Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer[J].Clin Exp Metastasis,2007,24(2):121-130.

相似文献/References:

[1]朱武凌 范秉琳.青年与老年结直肠癌C—erbB一2不同表达与DNA倍体的关系[J].新乡医学院学报,2002,19(03):170.
[2]王璧,王战会,韩保卫,等.Runt相关转录因子3在结直肠癌组织中的表达及意义[J].新乡医学院学报,2022,39(12):1127.[doi:10.7683/xxyxyxb.2022.12.005]
 WANG Bi,WANG Zhanhui,HAN Baowei,et al.Expression and significance of Runt-related transcription factor 3 in colorectal cancer[J].Journal of Xinxiang Medical University,2022,39(6):1127.[doi:10.7683/xxyxyxb.2022.12.005]
[3]齐光照,李朵璐.细胞色素P450酶CYP2W1研究进展[J].新乡医学院学报,2019,36(7):698.[doi:10.7683/xxyxyxb.2019.07.025]
[4]李怡春,张 敏,杨晓煜,等.CD133在人结直肠癌组织中的表达及其与缺氧诱导因子1α和核心蛋白聚糖的相关性[J].新乡医学院学报,2019,36(11):1036.[doi:10.7683/xxyxyxb.2019.11.007]
 LI Yi-chun,ZHANG Min,YANG Xiao-yu,et al.Expression of CD133 in human colorectal cancer tissues and correlation with hypoxia-induced factor-1α and decorin[J].Journal of Xinxiang Medical University,2019,36(6):1036.[doi:10.7683/xxyxyxb.2019.11.007]
[5]平贯芳,熊万成,邓智建.长链非编码RNA 浆细胞瘤转化迁移基因1在结直肠癌组织和细胞中的表达及临床意义[J].新乡医学院学报,2019,36(10):949.[doi:10.7683/xxyxyxb.2019.10.011]
 PING Guan-fang,XIONG Wan-cheng,DENG Zhi-jian.Expression and clinical significance of long-chain non-coding RNA plasmacytoma variant translocation gene 1 in colorectal cancer tissues and cells[J].Journal of Xinxiang Medical University,2019,36(6):949.[doi:10.7683/xxyxyxb.2019.10.011]
[6]吕文豪,董 媛,魏子白.二甲双胍在结直肠癌治疗中的作用研究进展[J].新乡医学院学报,2021,38(7):692.[doi:10.7683/xxyxyxb.2021.07.020]
[7]姬颖华,杨晓煜,孟祥丽,等.盐酸安罗替尼联合信迪利单抗治疗标准治疗失败后微卫星稳定型结直肠癌疗效观察[J].新乡医学院学报,2021,38(8):719.[doi:10.7683/xxyxyxb.2021.08.004]
 JI Yinghua,YANG Xiaoyu,MENG Xiangli,et al.Clinical efficacy of Anlotinib hydrochloride combined with Sintilimab in the treatment of microsatellite stable colorectal cancer after the failure of standard treatment[J].Journal of Xinxiang Medical University,2021,38(6):719.[doi:10.7683/xxyxyxb.2021.08.004]
[8]马 晓,陈国荣,李君艳,等.外周血中性粒细胞与淋巴细胞比值及血清癌胚抗原、糖类抗原199联合检测对结直肠癌的诊断价值[J].新乡医学院学报,2021,38(1):062.[doi:10.7683/xxyxyxb.2021.01.013]
 MA Xiao,CHEN Guorong,LI Junyan,et al.Value of combined detection of neutrophil-lymphocyte ratio in peripheral blood,serum carcinoembryonic antigen and carbohydrate antigen 199 in the diagnosis of colorectal cancer[J].Journal of Xinxiang Medical University,2021,38(6):062.[doi:10.7683/xxyxyxb.2021.01.013]
[9]谢 阳,赵李红,杨昌建,等.不同肺复张策略治疗腹腔镜下结直肠癌根治术患者围手术期肺不张疗效观察[J].新乡医学院学报,2021,38(9):857.[doi:10.7683/xxyxyxb.2021.09.012]
 XIE Yang,ZHAO Lihong,YANG Changjian,et al.Effect of different lung recruitment strategies in treatment of perioperative atelectasis of patients undergoing laparoscopic radical resection of colorectal cancer[J].Journal of Xinxiang Medical University,2021,38(6):857.[doi:10.7683/xxyxyxb.2021.09.012]
[10]胡德升,高 磊,王 江,等.外周血胸苷酸合成酶基因表达与中晚期结直肠癌患者FOLFOX4化学治疗敏感性和预后的相关性[J].新乡医学院学报,2020,37(10):930.[doi:10.7683/xxyxyxb.2020.10.007]
 HU Desheng,GAO Lei,WANG Jiang,et al.Correlation between thymidylate synthase gene expression in peripheral blood and FOLFOX4 chemotherapy sensitivity and prognosis of patients with advanced colorectal cancer[J].Journal of Xinxiang Medical University,2020,37(6):930.[doi:10.7683/xxyxyxb.2020.10.007]

更新日期/Last Update: 2018-06-05